Hèctor Corominas
Hèctor Corominas is an expert in Rheumatology at Hospital de Sant Pau (Spain). As of October 2026, ScienceLeadR ranks Hèctor Corominas in the top 1% of experts worldwide for Arthritis and Autoimmune Diseases. Hèctor Corominas has authored 307 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,146 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Immunology - Biochemistry - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 307
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Isolated, metabolic, and hypertensive gout: a population-based cluster analysis of 94,759 patients. PMID 42587427 — diabetes mellitus, comorbidity, phenotype, rheumatic diseases, cluster analysis, therapeutics, gout | Rheumatology (Oxford) | 2026 | 0 |
| Nervous system involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry. PMID 42340336 — registries, phenotype, peripheral nervous system, immunosuppressive agents, rheumatic diseases, sjogren's syndrome, myositis, diagnosis, therapeutics, nervous system, biological therapy | Mod Rheumatol | 2026 | 0 |
| Proof-of-concept study: longitudinal immune biomarker signatures in treatment-naïve IgG4-related disease. PMID 42277154 — cytokines, cells, longitudinal studies, serum, immunoglobulin g4-related disease, eosinophils, biomarkers, proof of concept study, complement system proteins, natural science disciplines, therapeutics | Sci Rep | 2026 | 0 |
| Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial. PMID 42135532 — confidence intervals, molecular biology, pharmaceutical preparations, arthritis, rheumatic diseases, abatacept, hydroxychloroquine, arthritis, rheumatoid, therapeutics | Nat Med Top journal | 2026 | 0 |
| Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study. PMID 42030169 — rheumatologists, perception, drug therapy, patient preference, research, biosimilar pharmaceuticals | Curr Med Res Opin | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map